cimadronate has been researched along with ipratropium bromide anhydrous in 1 studies
| Studies (cimadronate) | Trials (cimadronate) | Recent Studies (post-2010) (cimadronate) | Studies (ipratropium bromide anhydrous) | Trials (ipratropium bromide anhydrous) | Recent Studies (post-2010) (ipratropium bromide anhydrous) |
|---|---|---|---|---|---|
| 105 | 3 | 4 | 17 | 1 | 7 |
| Protein | Taxonomy | cimadronate (IC50) | ipratropium bromide anhydrous (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.0021 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0028 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0019 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
1 other study(ies) available for cimadronate and ipratropium bromide anhydrous
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |